Shumin Chen1, Jinlong Qu, Tongsheng Chu. 1. Shandong Provincial Institute of Dermatology, Shandong, P.R. China 250022. Chenshm@public.jn.sd.cn
Abstract
OBJECTIVES: To determine the prevalence and the characteristics of neuropathic pain among the people affected by leprosy in China. METHODS: People affected by leprosy in four leprosy villages were interviewed about neuropathic pain with an interviewer-administrated questionnaire. RESULTS: In a total of 275 patients with leprosy interviewed, 126 (45.8%) reported having symptoms suggestive of neuropathic pain. The pain was severe in 70 (55.5%) patients, moderate in 49 (38.9%) and mild in 7 (5.6%). Of the 126 patients with leprosy, 109 (86.5%) stated that the pain had some impact on their daily life: mild in 13 (10.3%), moderate in 45 (35.7%) and severe in 51 (40.5%). Sleep disturbance caused by pain was reported in 119 (94.4%) patients with leprosy: mild in 13 (10.3%), moderate in 51 (40.5%) and severe in 55 (43.6%). Ninety-six patients with leprosy (76.2%) reported that they had tried analgesics alone or in combination with steroids for the relief of their pain, of which 78 (81.2%) people reported that the treatment was effective. CONCLUSIONS: Neuropathic pain is not uncommon in both MB and PB patients who have completed effective antimicrobial treatment. The effectiveness of analgesics alone or in combination with steroids, in the treatment of neuropathic pain in patients with leprosy, needs to be studied.
OBJECTIVES: To determine the prevalence and the characteristics of neuropathic pain among the people affected by leprosy in China. METHODS:People affected by leprosy in four leprosy villages were interviewed about neuropathic pain with an interviewer-administrated questionnaire. RESULTS: In a total of 275 patients with leprosy interviewed, 126 (45.8%) reported having symptoms suggestive of neuropathic pain. The pain was severe in 70 (55.5%) patients, moderate in 49 (38.9%) and mild in 7 (5.6%). Of the 126 patients with leprosy, 109 (86.5%) stated that the pain had some impact on their daily life: mild in 13 (10.3%), moderate in 45 (35.7%) and severe in 51 (40.5%). Sleep disturbance caused by pain was reported in 119 (94.4%) patients with leprosy: mild in 13 (10.3%), moderate in 51 (40.5%) and severe in 55 (43.6%). Ninety-six patients with leprosy (76.2%) reported that they had tried analgesics alone or in combination with steroids for the relief of their pain, of which 78 (81.2%) people reported that the treatment was effective. CONCLUSIONS:Neuropathic pain is not uncommon in both MB and PB patients who have completed effective antimicrobial treatment. The effectiveness of analgesics alone or in combination with steroids, in the treatment of neuropathic pain in patients with leprosy, needs to be studied.
Authors: José Manuel Ramos; Beatriz Alonso-Castañeda; Dejene Eshetu; Deriba Lemma; Francisco Reyes; Isabel Belinchón; Miguel Górgolas Journal: Pathog Glob Health Date: 2014-06-03 Impact factor: 2.894
Authors: Louise Mara Giesel; Izabela Jardim Rodrigues Pitta; Raquel Custódio da Silveira; Lígia Rocha Andrade; Robson Teixeira Vital; José Augusto da Costa Nery; Mariana de Andrea Vilas Boas Hacker; Euzenir Nunes Sarno; Marcia Maria Jardim Rodrigues Journal: Am J Trop Med Hyg Date: 2018-03-29 Impact factor: 2.345
Authors: Victor S Santos; Jamilly C V Santana; Fabrícia D N Castro; Laudice S Oliveira; Julianne C V Santana; Vera L C Feitosa; Ricardo Q Gurgel; Luis E Cuevas Journal: Infect Dis Poverty Date: 2016-03-07 Impact factor: 4.520
Authors: Rogerio Del Arco; Susilene Maria Tonelli Nardi; Thiago Gasperini Bassi; Vania Del Arco Paschoal Journal: Rev Lat Am Enfermagem Date: 2016-08-08
Authors: Irina Raicher; Patrick Raymond Nicolas Andre Ghislain Stump; Simone Bega Harnik; Rodrigo Alves de Oliveira; Rosemari Baccarelli; Lucia H S C Marciano; Somei Ura; Marcos C L Virmond; Manoel Jacobsen Teixeira; Daniel Ciampi de Andrade Journal: Pain Rep Date: 2018-02-23